Burzynski Research Institute, Inc. (BZYR)
OTCMKTS · Delayed Price · Currency is USD
0.01934
+0.003065 (18.83%)
At close: May 5, 2026
BZYR Market Cap
BZYR has a market cap or net worth of $2.54 million as of May 6, 2026. Its market cap has decreased by -44.74% in one year.
Market Cap
2.54M
Enterprise Value
2.54M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.02
Market Cap Chart
Since April 28, 1997, BZYR's market cap has decreased from 16.41M to 2.54M, a decrease of -84.51%. That is a compound annual growth rate of -6.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 4, 2026 | 2.14M | -14.79% |
| Dec 29, 2025 | 2.51M | -38.39% |
| Dec 31, 2024 | 4.07M | -29.55% |
| Dec 29, 2023 | 5.78M | 70.28% |
| Dec 23, 2022 | 3.40M | 115.33% |
| Dec 31, 2021 | 1.58M | -33.33% |
| Dec 16, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oncology Pharma | 2.71M |
| Vaccinex | 2.68M |
| VitaSpring Biomedical | 2.30M |
| ProtoKinetix | 2.21M |
| Iterum Therapeutics | 2.07M |
| Avenue Therapeutics | 2.00M |
| Enzolytics | 1.93M |
| AXIM Biotechnologies | 1.89M |